BridgeMD
Prevention study for ERCP Surgery
Official title Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis.
ClinicalTrials.gov ID: NCT05667987
What this study is testing
What is Intravenous lidocaine administration?
Intravenous lidocaine administration is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for ercp surgery.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this study is, in a population of patients undergoing ERCP surgery, treated preventively with NSAIDs and divided into two groups according to the absence (group 1) or presence (group 2) of intravenous lidocaine in the general anesthesia protocol. The main objective of this study is to compare the incidence of post-ERCP pancreatitis between the two groups.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient over 18 years of age
- Patient who has read and signed the consent form for participation in the study
- Patient candidate for ERCP with virgin papilla
You likely can't join if
- Patient with sphincterotomized papilla
- Patient under court protection, guardianship or curatorship
- Pregnant woman or woman of childbearing age without highly effective contraception for the duration of the study (surgically sterile, intrauterine...
- Patient not affiliated with the French social security system
- Patient participating in another clinical research protocol
- Impossibility to give the subject informed information and/or written informed consent: dementia, psychosis, disorders of consciousness, non-French...
See the full eligibility criteria
- Patient over 18 years of age
- Patient who has read and signed the consent form for participation in the study
- Patient candidate for ERCP with virgin papilla
- Patient with sphincterotomized papilla
- Patient under court protection, guardianship or curatorship
- Pregnant woman or woman of childbearing age without highly effective contraception for the duration of the study (surgically sterile, intrauterine device (\> 14 days), hormonal contraception (same dose and formulation...
- Patient not affiliated with the French social security system
- Patient participating in another clinical research protocol
- Impossibility to give the subject informed information and/or written informed consent: dementia, psychosis, disorders of consciousness, non-French speaking patient
- Contraindication to the use of NSAIDs
- Contraindication to anesthesia or to the administration of any of the products used in anesthesia protocols (including lidocaine)
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.